Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19.

Julij Šelb, Barbara Bitežnik,Urška Bidovec Stojković,Boštjan Rituper,Katarina Osolnik,Peter Kopač, Petra Svetina, Kristina Cerk Porenta,Franc Šifrer, Petra Lorber, Darinka Trinkaus Leiler, Tomaž Hafner, Tina Jerič,Robert Marčun,Nika Lalek,Nina Frelih,Mojca Bizjak, Rok Lombar, Vesna Nikolić,Katja Adamič,Katja Mohorčič, Sanja Grm Zupan,Irena Šarc,Jerneja Debeljak,Ana Koren, Ajda Demšar Luzar,Matija Rijavec,Izidor Kern,Matjaž Fležar,Aleš Rozman,Peter Korošec

ERJ Open Research(2022)

引用 0|浏览8
暂无评分
摘要
Background:The relationship between anti-SARS-CoV-2 humoral immune response, pathogenic inflammation, lymphocytes and fatal COVID-19 is poorly understood. Methods:A longitudinal prospective cohort of hospitalised patients with COVID-19 (n=254) was followed up to 35 days after admission (median, 8 days). We measured early anti-SARS-CoV-2 S1 antibody IgG levels and dynamic (698 samples) of quantitative circulating T-, B- and natural killer lymphocyte subsets and serum interleukin-6 (IL-6) response. We used machine learning to identify patterns of the immune response and related these patterns to the primary outcome of 28-day mortality in analyses adjusted for clinical severity factors. Results:Overall, 45 (18%) patients died within 28 days after hospitalisation. We identified six clusters representing discrete anti-SARS-CoV-2 immunophenotypes. Clusters differed considerably in COVID-19 survival. Two clusters, the anti-S1-IgGlowestTlowestBlowestNKmodIL-6mod, and the anti-S1-IgGhighTlowBmodNKmodIL-6highest had a high risk of fatal COVID-19 (HR 3.36-21.69; 95% CI 1.51-163.61 and HR 8.39-10.79; 95% CI 1.20-82.67; p≤0.03, respectively). The anti-S1-IgGhighestTlowestBmodNKmodIL-6mod and anti-S1-IgGlowThighestBhighestNKhighestIL-6low cluster were associated with moderate risk of mortality. In contrast, two clusters the anti-S1-IgGhighThighBmodNKmodIL-6low and anti-S1-IgGhighestThighestBhighNKhighIL-6lowest clusters were characterised by a very low risk of mortality. Conclusions:By employing unsupervised machine learning we identified multiple anti-SARS-CoV-2 immune response clusters and observed major differences in COVID-19 mortality between these clusters. Two discrete immune pathways may lead to fatal COVID-19. One is driven by impaired or delayed antiviral humoral immunity, independently of hyper-inflammation, and the other may arise through excessive IL-6-mediated host inflammation response, independently of the protective humoral response. Those observations could be explored further for application in clinical practice.
更多
查看译文
关键词
anti-sars-cov
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要